Netcapital to Host Planned Reg A Offering by Algernon NeuroScience

Core Insights - Netcapital Inc. has engaged its subsidiary, Netcapital Securities Inc., to provide broker-dealer and administrative services for Algernon NeuroScience's planned Regulation A offering [1][2] - Algernon NeuroScience has filed a Form 1-A with the SEC, and the offering is pending qualification [2][4] - Proceeds from the offering are intended to support Algernon's research and development initiatives [2] Company Overview - Netcapital Inc. operates a fintech platform that facilitates capital raising for private companies and offers private equity investment opportunities [6] - Netcapital Securities Inc. is a FINRA-registered broker-dealer and provides compliance and operational support for offerings [1][6] - Algernon NeuroScience is a subsidiary of Algernon Pharmaceuticals focused on advancing a psychedelic DMT program for stroke and traumatic brain injury [7]